SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Citi Maintains Buy Rating on Sinopharm Group

Citi maintained its Buy rating on Sinopharm Group.

SquawkNews Desk

Related stories

Allegro Microsystems Reports Quarterly Results Through September 30 M impact | EQUITY | Oct 29, 2026, 07:12 PM UTC Group 1 Automotive Reports Third-Quarter Revenue of $5.4B Third-quarter revenue fell 6.7% year over year to $5.4 billion. Net income rose to $102.9 million from $13 million; diluted EPS was $8.59. M impact | EQUITY | Oct 29, 2026, 07:11 PM UTC Visa Publishes Q4 and Full-Year 2026 Earnings Call Transcript M impact | EQUITY | Oct 29, 2026, 07:11 PM UTC Alphabet Shares Trigger Death Cross After Post-Earnings Slide Alphabet shares entered bearish territory after a post-earnings skid. The report says shares rebounded after four of the past five death crosses over the last decade, with an avera M impact | EQUITY | Oct 29, 2026, 07:10 PM UTC CVC Acquires Stake in Recordati CVC acquired shares in Recordati on October 29, 2026. M impact | EQUITY | Oct 29, 2026, 07:09 PM UTC Perella Weinberg Partners Reports Quarterly Results Perella Weinberg Partners reported results for the quarter ended September 30. M impact | EQUITY | Oct 29, 2026, 07:09 PM UTC